These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Conservative therapy in the Parkinson syndrome]. Birkmayer W Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823 [No Abstract] [Full Text] [Related]
12. [Current treatment of the Parkinsonian syndrome]. Voiculescu V Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485 [No Abstract] [Full Text] [Related]
13. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases]. Sigwald J; Raymondeaud C Nouv Presse Med; 1972 Apr; 1(18):1237-9. PubMed ID: 5025538 [No Abstract] [Full Text] [Related]
14. [Therapy of Parkinson's syndrome]. Hirschmann J Med Welt; 1973 Jun; 24(23):976-9. PubMed ID: 4744991 [No Abstract] [Full Text] [Related]
15. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease]. Fasano VA; Urciuoli R; Broggi G Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170 [No Abstract] [Full Text] [Related]
16. [Drug therapy of Parkinson's disease with amantadine and levodopa]. Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552 [No Abstract] [Full Text] [Related]
17. [L-dopa and Parkinson's disease]. Barbeau A Union Med Can; 1970 Dec; 99(12):2195-7. PubMed ID: 5488646 [No Abstract] [Full Text] [Related]
18. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine]. Sigwald J; Raymondeaud C; Piot C Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718 [No Abstract] [Full Text] [Related]
19. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor]. Guillard A Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191 [No Abstract] [Full Text] [Related]
20. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)]. Schneider E; Fischer PA; Jacobi P Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456 [No Abstract] [Full Text] [Related] [Next] [New Search]